Financhill
Buy
60

VRTX Quote, Financials, Valuation and Earnings

Last price:
$512.40
Seasonality move :
11.16%
Day range:
$504.00 - $517.20
52-week range:
$377.85 - $519.88
Dividend yield:
0%
P/E ratio:
26.10x
P/S ratio:
12.09x
P/B ratio:
8.04x
Volume:
1.1M
Avg. volume:
1.4M
1-year change:
26.02%
Market cap:
$131.9B
Revenue:
$11B
EPS (TTM):
-$2.20

Vertex Pharmaceuticals SEC Filings

Company Filed Form Type Description
VRTX
Vertex Pharmaceuticals
05/07/2024 10-Q 10-Q filing on 05/07/2024 View Form
VRTX
Vertex Pharmaceuticals
02/15/2024 10-K 10-K filing on 02/15/2024 View Form
VRTX
Vertex Pharmaceuticals
11/07/2023 10-Q 10-Q filing on 11/07/2023 View Form
VRTX
Vertex Pharmaceuticals
08/02/2023 10-Q 10-Q filing on 08/02/2023 View Form
VRTX
Vertex Pharmaceuticals
05/02/2023 10-Q 10-Q filing on 05/02/2023 View Form
VRTX
Vertex Pharmaceuticals
02/10/2023 10-K 10-K filing on 02/10/2023 View Form
VRTX
Vertex Pharmaceuticals
10/28/2022 10-Q 10-Q filing on 10/28/2022 View Form
VRTX
Vertex Pharmaceuticals
08/05/2022 10-Q 10-Q filing on 08/05/2022 View Form
VRTX
Vertex Pharmaceuticals
05/06/2022 10-Q 10-Q filing on 05/06/2022 View Form
VRTX
Vertex Pharmaceuticals
02/09/2022 10-K 10-K filing on 02/09/2022 View Form
VRTX
Vertex Pharmaceuticals
11/03/2021 10-Q 10-Q filing on 11/03/2021 View Form
VRTX
Vertex Pharmaceuticals
07/30/2021 10-Q 10-Q filing on 07/30/2021 View Form
VRTX
Vertex Pharmaceuticals
04/30/2021 10-Q 10-Q filing on 04/30/2021 View Form
VRTX
Vertex Pharmaceuticals
02/11/2021 10-K 10-K filing on 02/11/2021 View Form
VRTX
Vertex Pharmaceuticals
10/30/2020 10-Q 10-Q filing on 10/30/2020 View Form
VRTX
Vertex Pharmaceuticals
07/31/2020 10-Q 10-Q filing on 07/31/2020 View Form
VRTX
Vertex Pharmaceuticals
05/01/2020 10-Q 10-Q filing on 05/01/2020 View Form
VRTX
Vertex Pharmaceuticals
02/13/2020 10-K 10-K filing on 02/13/2020 View Form
VRTX
Vertex Pharmaceuticals
10/31/2019 10-Q 10-Q filing on 10/31/2019 View Form
VRTX
Vertex Pharmaceuticals
08/01/2019 10-Q 10-Q filing on 08/01/2019 View Form
VRTX
Vertex Pharmaceuticals
05/01/2019 10-Q 10-Q filing on 05/01/2019 View Form
VRTX
Vertex Pharmaceuticals
02/13/2019 10-K 10-K filing on 02/13/2019 View Form
VRTX
Vertex Pharmaceuticals
10/25/2018 10-Q 10-Q filing on 10/25/2018 View Form
VRTX
Vertex Pharmaceuticals
07/26/2018 10-Q 10-Q filing on 07/26/2018 View Form
VRTX
Vertex Pharmaceuticals
04/27/2018 10-Q 10-Q filing on 04/27/2018 View Form
VRTX
Vertex Pharmaceuticals
02/15/2018 10-K 10-K filing on 02/15/2018 View Form
VRTX
Vertex Pharmaceuticals
10/30/2017 10-Q 10-Q filing on 10/30/2017 View Form
VRTX
Vertex Pharmaceuticals
07/28/2017 10-Q 10-Q filing on 07/28/2017 View Form
VRTX
Vertex Pharmaceuticals
04/28/2017 10-Q 10-Q filing on 04/28/2017 View Form
VRTX
Vertex Pharmaceuticals
02/23/2017 10-K 10-K filing on 02/23/2017 View Form
VRTX
Vertex Pharmaceuticals
10/31/2016 10-Q 10-Q filing on 10/31/2016 View Form
VRTX
Vertex Pharmaceuticals
08/01/2016 10-Q 10-Q filing on 08/01/2016 View Form
VRTX
Vertex Pharmaceuticals
05/03/2016 10-Q 10-Q filing on 05/03/2016 View Form
VRTX
Vertex Pharmaceuticals
02/16/2016 10-K 10-K filing on 02/16/2016 View Form
VRTX
Vertex Pharmaceuticals
10/30/2015 10-Q 10-Q filing on 10/30/2015 View Form
VRTX
Vertex Pharmaceuticals
08/04/2015 10-Q 10-Q filing on 08/04/2015 View Form
VRTX
Vertex Pharmaceuticals
05/04/2015 10-Q 10-Q filing on 05/04/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock